{"product_id":"lianhetech-pestle-analysis","title":"Lianhe Chemical Technology Co. PESTLE Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMake Smarter Strategic Decisions with a Complete PESTEL View\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eOur PESTLE analysis for Lianhe Chemical Technology Co. reveals how regulatory shifts, raw-material cycles, tech adoption, and ESG pressures could reshape its competitive edge and margins; we translate these trends into strategic implications for investors and managers. Gain the full, actionable report with ready-to-use insights and forecasts—purchase the complete PESTLE now to inform your next decision.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eolitical factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eChina industrial policy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAlignment with Beijing’s advanced manufacturing and green chemistry priorities—featured in the 14th Five-Year Plan and national strategic catalogs—can unlock access to 2,600+ national industrial parks, VAT rebates and capped local subsidies. Policy shifts can re-route subsidies or tighten new-capacity approvals, with environmental permitting often adding 90–180 days. Lianhe must map projects to catalogs and coordinate with local governments for land, utilities and faster timelines.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTrade tensions and tariffs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eUS Section 301 tariffs, often up to 25%, and EU measures create direct cost shocks to intermediates and APIs, raising cost-to-serve for 2024 supply chains. Non-tariff barriers such as origin rules and intensified audits add compliance delay and expense. Diversifying export markets and capex footprints reduces single‑lane exposure, while proactive customer pricing clauses help preserve margins amid tariff volatility.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGeopolitical supply security\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eClients now demand dual sourcing and resilient supply from politically stable hubs, a trend amplified by 2020–2024 disruption cycles that saw many buyers reconfigure supplier bases. Sanctions and export controls—illustrated by restrictions on select chemistries in recent years—can abruptly halt programs, so Lianhe’s strategy of multi-country production plus inventory buffers underpins continuity. Enhanced government-to-government cooperation has been used since COVID to fast-track critical pharma and agro inputs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory nationalism\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eRegulatory nationalism drives localization mandates in pharma and agrochemicals, forcing Lianhe to shift value-added steps onshore; by 2024 over 50 jurisdictions enacted measures favoring local production, impacting where APIs and formulation work occur. Preference for domestic suppliers in public procurement raises tender risk for exported APIs and crop-protection products, while heightened technology-transfer sensitivities lengthen and tighten contract terms. Lianhe must adopt legal and operational structures that balance local-content compliance with strict IP and data-protection measures to protect proprietary chemistries.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLocalization: \u0026gt;50 jurisdictions with measures (2024)\u003c\/li\u003e\n\u003cli\u003ePublic procurement: increased tender preference for domestic suppliers\u003c\/li\u003e\n\u003cli\u003eContracts: stronger tech-transfer safeguards\u003c\/li\u003e\n\u003cli\u003eStrategy: local presence + IP control\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePublic health and food security agendas\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003ePolicy emphasis on staple yields and medicine access in China (pharma market ~184 billion USD in 2024) underpins steady demand for CP and API intermediates; registration priorities and NMPA fast-track pathways have cut review times by roughly 40%, accelerating launches. A shift toward low-toxicity chemicals and biologicals could require portfolio pivots; proactive engagement with regulators aligns pipeline with national targets.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDemand driver: food\/security + medicine access\u003c\/li\u003e\n\u003cli\u003eMarket size: China pharma ~184B USD (2024)\u003c\/li\u003e\n\u003cli\u003eRegulatory: fast-track ≈40% faster reviews\u003c\/li\u003e\n\u003cli\u003eRisk: pivot to biologicals\/low-toxicity\u003c\/li\u003e\n\u003cli\u003eMitigation: agency engagement\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eChina pharma \u003cstrong\u003e$184B\u003c\/strong\u003e, tariffs \u003cstrong\u003e25%\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAlignment with Beijing priorities (14th FYP) unlocks VAT rebates, 2,600+ national parks and capped subsidies; environmental permits add 90–180 days. US Section 301 tariffs up to 25% and \u0026gt;50 localization laws (2024) raise export\/tender risk. China pharma ≈184B USD (2024); NMPA fast-track ≈40% faster reviews.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eFactor\u003c\/th\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eImpact\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eIndustrial policy\u003c\/td\u003e\n\u003ctd\u003e2,600+ parks\u003c\/td\u003e\n\u003ctd\u003ePreferential access\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePermitting\u003c\/td\u003e\n\u003ctd\u003e90–180 days\u003c\/td\u003e\n\u003ctd\u003eTimeline delay\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTariffs\/localization\u003c\/td\u003e\n\u003ctd\u003e25%\/\u0026gt;50 juris.\u003c\/td\u003e\n\u003ctd\u003eCost\/tender risk\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMarket\/regulation\u003c\/td\u003e\n\u003ctd\u003eChina pharma $184B; NMPA −40%\u003c\/td\u003e\n\u003ctd\u003eDemand + faster launches\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eExplores how macro-environmental forces—Political, Economic, Social, Technological, Environmental, and Legal—specifically impact Lianhe Chemical Technology Co., combining current data and trends to highlight risks, opportunities, and strategic implications for executives, investors, and advisors.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, PESTLE-segmented summary of Lianhe Chemical Technology Co. that relieves pain by distilling regulatory, economic, social, technological, environmental and political risks into an editable, presentation-ready snapshot for quick team alignment and strategic decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eE\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003economic factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal demand cycles\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGlobal demand cycles for Lianhe Chemical are driven by agrochemical seasonality (global agrochemical market ~USD 66bn in 2024), staggered pharma launches (dozens of novel drug approvals in 2024) and specialty end-market campaigns, producing pronounced order variability.\u003c\/p\u003e\n\u003cp\u003eInventory corrections in 2024 trimmed plant utilization, then rebounded sharply during upcycles.\u003c\/p\u003e\n\u003cp\u003eFlexible assets and campaign planning have smoothed quarterly earnings.\u003c\/p\u003e\n\u003cp\u003eForward hedging of capacity and feedstock secures throughput, preventing bottlenecks at upcycles.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInput cost volatility\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePrices for solvents, reagents and energy materially drive Lianhe Chemical’s COGS; Brent crude averaged about $86\/bbl in 2024 and Henry Hub gas near $2.9\/MMBtu, with swings in 2024–25 rippling through petrochemical chains. Indexed contracts and formula pricing increasingly protect margin spreads by tying feedstock costs to benchmarks. Process intensification initiatives have reduced variable cost per kg by double-digit percentages in pilot runs, improving cycle economics.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFX exposure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eLianhe Chemical faces translation and transaction risk as a portion of revenues invoiced in USD\/EUR must be converted against RMB costs; USD\/CNY hovered near 7.3 in mid-2025, amplifying NAV volatility. Currency swings alter export competitiveness and can delay or reshape capex choices when RMB weakens versus major currencies. Active hedging programs and natural offsets from imported raw materials materially cut net FX exposure. Multi-currency pricing with key clients stabilizes cash flows and reduces translation mismatch.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCapital intensity and ROIC\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eCustom manufacturing for Lianhe Chemical demands high capital investment to build EHS-compliant, contained plants; this raises capital intensity and pressures ROIC unless matched by contract certainty. A higher share of long-term contracts improves asset turns versus spot work. Stage-gated investments tied to customer commitments raise realized ROIC. Modular, skidded plants shorten payback and allow capacity to follow demand.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCapex: EHS containment drives fixed costs\u003c\/li\u003e\n\u003cli\u003eContracts: long-term boosts asset turns\u003c\/li\u003e\n\u003cli\u003eStage-gating: links spend to revenue, improving ROIC\u003c\/li\u003e\n\u003cli\u003eModular plants: faster payback, demand alignment\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCredit and liquidity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eTightening credit raises borrowing costs for Lianhe Chemical, pressuring capex and working capital; customer credit risk in downturns increases DSO and bad-debt exposure, while diversified funding, supply-chain finance and efficient cash conversion cycles improve resilience; a strong balance sheet enables opportunistic M\u0026amp;A and strategic investments.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigher borrowing costs reduce expansion pace\u003c\/li\u003e\n\u003cli\u003eDownturns raise customer credit risk and DSO\u003c\/li\u003e\n\u003cli\u003eDiversified funding and SCF enhance liquidity\u003c\/li\u003e\n\u003cli\u003eSolid balance sheet supports M\u0026amp;A\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eChina pharma \u003cstrong\u003e$184B\u003c\/strong\u003e, tariffs \u003cstrong\u003e25%\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGlobal demand cycles (agrochemical market ~USD 66bn in 2024) and staggered pharma launches create pronounced order variability. Brent ~$86\/bbl and Henry Hub ~$2.9\/MMBtu in 2024 materially drive COGS; indexed contracts and process intensification have improved margins. USD\/CNY ~7.3 mid-2025 raises FX risk; hedging, modular plants and strong liquidity mitigate capex and credit pressure.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\/2025\u003c\/th\u003e\n\u003cth\u003eImpact\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eAgrochemical market\u003c\/td\u003e\n\u003ctd\u003e~USD 66bn (2024)\u003c\/td\u003e\n\u003ctd\u003eSeasonal demand swings\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBrent\u003c\/td\u003e\n\u003ctd\u003e~USD 86\/bbl (2024)\u003c\/td\u003e\n\u003ctd\u003eDrives COGS\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHenry Hub\u003c\/td\u003e\n\u003ctd\u003e~USD 2.9\/MMBtu (2024)\u003c\/td\u003e\n\u003ctd\u003eEnergy cost\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUSD\/CNY\u003c\/td\u003e\n\u003ctd\u003e~7.3 (mid-2025)\u003c\/td\u003e\n\u003ctd\u003eFX\/competitiveness\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eLianhe Chemical Technology Co. PESTLE Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown is the exact, fully formatted Lianhe Chemical Technology Co. PESTLE analysis you’ll receive after purchase. It includes Political, Economic, Social, Technological, Legal and Environmental sections with professional structure and no placeholders. What you see is the final downloadable file.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":56162734965113,"sku":"lianhetech-pestle-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/lianhetech-pestle-analysis.png?v=1762707998","url":"https:\/\/portersfiveforce.com\/products\/lianhetech-pestle-analysis","provider":"Porter's Five Forces","version":"1.0","type":"link"}